Growth in the biological safety cabinets market is primarily driven by factors such as favorable regulations driving the use of biological safety cabinets in the healthcare industry, increased risk of pandemics and communicable diseases, increasing number of R&D activities in biotechnological and pharmaceutical companies, and rapid growth in the number of biologics.
The Biological Safety Cabinet Market is projected to
reach USD 205.9 Million by 2022 from USD 144.3 Million in 2017, at a CAGR of
7.4%.
Ask for PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=60228904
The Class II biological safety cabinets segment accounted for
the largest share of the market in 2017
On the basis of type, the biological safety cabinets market has
been segmented into Class I, Class II, and Class III biological safety cabinets.
The Class II biological safety cabinets segment accounted for the largest share
of the biological safety cabinet’s market in 2017. The large share and high
growth of this segment can primarily be attributed to the high level of
protection offered by these cabinets.
Pharmaceutical & biopharmaceutical companies held the
largest share of the market in 2017
On the basis of end user, the biological safety cabinets market
has been segmented into pharmaceutical & biopharmaceutical companies,
diagnostic and testing laboratories, and academic & research institutions.
In 2017, the pharmaceutical & biopharmaceutical companies segment accounted
for the largest share of the biological safety cabinets market. This segment is
also projected to grow at the highest CAGR during the forecast period. The
large share and high growth of the market can be attributed to the increasing
demand for drug development and the need to ensure the safety of laboratory
personnel.
North America to dominate the market in 2017
In 2017, North America accounted for the largest share of the
biological safety cabinets market, followed by Europe. The large share of the
North American region can be attributed to the increasing biomedical research
and R&D by pharmaceutical companies in the region, growing stem cell
research, government support for research in the US, and government support for
the development of protein drugs in Canada, which increases the need for
biological safety cabinets.
Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=60228904
The major market players in the biological safety cabinets
market include Thermo Fisher Scientific (US), Esco Micro (Singapore), Labconco
(US), The Baker Company (US), Kewaunee Scientific (US), NuAire (US), Germfree
Laboratories (US), EUROCLONE (Italy), Cruma (Spain), Air Science (US), Berner
International (Germany), and BIOBASE (China)
No comments:
Post a Comment